The study suggests that plasma NfL, along with other biomarkers, can differentiate diagnostic groups, hinting at its potential as a prognostic biomarker in Alzheimer's disease outside of research settings [94, 108, 109]. Here, NEFL is linked to early-onset autosomal dominant Alzheimer disease.